Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15–64-year-olds in Europe: exploration by birth cohort
Esther Kissling, Silke Buda(Robert Koch Institute), Mariëtte Hooiveld(Netherlands Institute for Health Services Research), Mihaela Lazăr, Lisa Domegan(Health Service Executive), Verónica Gomez(National Institute of Health Dr. Ricardo Jorge), Goranka Petrović(Hrvatski zavod za javno zdravstvo), Marta Valenciano(World Health Organization), Pasi Penttinen(European Centre for Disease Prevention and Control), Mia Brytting, Adam Meijer(National Centre for Infectious Diseases), Francisco Pozo(Instituto de Salud Carlos III), Ralf Dürrwald(IDT Biologika (Germany)), Amparo Larrauri(Instituto de Salud Carlos III), Alin Gherasim(Instituto de Salud Carlos III), Vesna Višekruna Vučina(Hrvatski zavod za javno zdravstvo), Joan O’Donnell(Health Service Executive), Raquel Guiomar, Theresa Enkirch(Public Health Agency of Sweden), Елена Юлиевна Стоян(Institutul Cantacuzino), Sylvie van der Werf(Centre National de la Recherche Scientifique), Ana‐Maria Vilcu(Inserm)
Cited by 48
Related Papers
Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome
|New England Journal of Medicine|2003|4.8k
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
|The Lancet|2003|1.1k
Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands
|The Lancet|2004|833
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|715
Global Disease Burden Estimates of Respiratory Syncytial Virus–Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis
|The Journal of Infectious Diseases|2019|534